Annexon Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	29.97	33.1	30.65	14.2	7.99	3.62
Research & Development	113.76	112.5	100.07	49.27	24.52	15.53
Operating Expenses	143.72	145.6	130.71	63.47	32.52	19.15
Operating Income	-143.72	-145.6	-130.71	-63.47	-32.52	-19.15
Other Expense / Income	-9.49	-3.65	-0.39	-0.06	4.66	-0.84
Pretax Income	-134.24	-141.95	-130.32	-63.41	-37.18	-18.3
Income Tax	0	0	0	0	0	0
Net Income	-134.24	-141.95	-130.32	-63.41	-37.18	-18.3
Preferred Dividends	0	0	0	6.92	1.1	0.18
Net Income Common	-134.24	-141.95	-130.32	-70.34	-38.28	-18.48
Shares Outstanding (Basic)	76	55	38	17	0	0
Shares Outstanding (Diluted)	76	55	38	17	0	0
Shares Change	38.41%	42.69%	125.89%	3812.96%	7.64%	-
EPS (Basic)	-1.77	-2.60	-3.40	-4.15	-88.30	-45.89
EPS (Diluted)	-1.77	-2.60	-3.40	-4.15	-88.30	-45.89
Free Cash Flow	-121.34	-122.84	-107.76	-53.55	-28.63	-17.21
Free Cash Flow Per Share	-1.60	-2.25	-2.81	-3.16	-66.03	-42.73
EBITDA	-130.97	-138.64	-126.91	-62.75	-36.69	-17.82
Depreciation & Amortization	3.27	3.31	3.41	0.67	0.49	0.49
EBIT	-134.24	-141.95	-130.32	-63.41	-37.18	-18.3

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).